The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients von Treon, Steven P., Castillo, Jorge J., Skarbnik, Alan P., Soumerai, Jacob D., Ghobrial, Irene M., Guerrera, Maria Luisa, Meid, Kirsten, Yang, Guang

Volltext

Case 16-2022: A Man with Fevers, Night Sweats, and a Mediastinal Mass. Reply von Soumerai, Jacob D

Volltext

Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicentre, first-in... von Pagel, John M, Soumerai, Jacob D, Reddy, Nishitha, Jagadeesh, Deepa, Stathis, Anastasios, Asch, Adam, Salman, Huda, Kenkre, Vaishalee P, Iasonos, Alexia, Llorin-Sangalang, Judith, Li, Joanne, Zelenetz, Andrew D

Volltext

Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL von Siddiqi, Tanya, Soumerai, Jacob D., Dorritie, Kathleen A., Stephens, Deborah M., Riedell, Peter A., Arnason, Jon, Kipps, Thomas J., Gillenwater, Heidi H., Gong, Lucy, Yang, Lin, Ogasawara, Ken, Thorpe, Jerill, Wierda, William G.

Volltext

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells von Karschnia, Philipp, Jordan, Justin T., Forst, Deborah A., Arrillaga-Romany, Isabel C., Batchelor, Tracy T., Baehring, Joachim M., Clement, Nathan F., Gonzalez Castro, L. Nicolas, Herlopian, Aline, Maus, Marcela V., Schwaiblmair, Michaela H., Soumerai, Jacob D., Takvorian, Ronald W., Hochberg, Ephraim P., Barnes, Jeffrey A., Abramson, Jeremy S., Frigault, Matthew J., Dietrich, Jorg

Volltext

Diagnosis and management of Castleman disease von Soumerai, Jacob D, Sohani, Aliyah R, Abramson, Jeremy S

Volltext

Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial von Neilan, Tomas G, Quinaglia, Thiago, Onoue, Takeshi, Mahmood, Syed S, Drobni, Zsofia D, Gilman, Hannah K, Smith, Amanda, Heemelaar, Julius C, Brahmbhatt, Priya, Ho, Jor Sam, Sama, Supraja, Svoboda, Jakub, Neuberg, Donna S, Abramson, Jeremy S, Hochberg, Ephraim P, Barnes, Jefferey A, Armand, Philippe, Jacobsen, Eric D, Jacobson, Caron A, Kim, Austin I, Soumerai, Jacob D, Han, Yuchi, Friedman, Robb S, Lacasce, Ann S, Ky, Bonnie, Landsburg, Dan, Nasta, Sunita, Kwong, Raymond Y, Jerosch-Herold, Michael, Redd, Robert A, Hua, Lanqi, Januzzi, James L, Asnani, Aarti, Mousavi, Negareh, Scherrer-Crosbie, Marielle

Volltext

Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180 von TREON, Steven P, LOAKIMIDIS, Leukothea, KEOGH, George P, MYERS, Thomas J, BORAL, Andy, BIRNER, Ann, ESSELTINE, Dixie L, GHOBRIAL, Irene M, SOUMERAI, Jacob D, PATTERSON, Christopher J. J, SHEEHY, Patricia, NELSON, Marybeth, WILLEN, Michael, MATOUS, Jeffrey, MATTERN, John, DIENER, Jakow G

Volltext

Case 16-2022: A 55-Year-Old Man with Fevers, Night Sweats, and a Mediastinal Mass von Fajgenbaum, David C., Goiffon, Reece J., Soumerai, Jacob D., Harris, Cynthia K.

Volltext

Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma von Miller, Kevin Charles, Johnson, Patrick Connor, Abramson, Jeremy S., Soumerai, Jacob D., Yee, Andrew J., Branagan, Andrew R., O’Donnell, Elizabeth K., Saucier, Anna, Jacobson, Caron A., Frigault, Matthew J., Raje, Noopur S.

Volltext

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups von Batlevi, Connie L., Sha, Fushen, Alperovich, Anna, Ni, Ai, Smith, Katy, Ying, Zhitao, Soumerai, Jacob D., Caron, Philip C., Falchi, Lorenzo, Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Joffe, Erel, Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Moskowitz, Craig H., Noy, Ariela, Owens, Colette, Palomba, Lia M., Straus, David, von Keudell, Gottfried, Zelenetz, Andrew D., Seshan, Venkatraman E., Younes, Anas

Volltext

Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas von Soumerai, Jacob D., Diefenbach, Catherine S., Jagadeesh, Deepa, Asch, Adam, Kumar, Abhijeet, Tsai, Michaela L., Jandl, Thomas A., Lossos, Izidore S., Kenkre, Vaishalee P., Awan, Farrukh, Novotny, William, Huang, Jane, Miao, Lu, Rajagopalan, Prabhu, Ghalie, Richard G., Zelenetz, Andrew D.

Volltext

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma von Soumerai, Jacob D., Rosenthal, Allison, Harkins, Shannon, Duffy, Jessica, Mecca, Carmen, Wang, Yingbing, Grewal, Ravinder K., El-Jawahri, Areej R., Liu, Huiyun, Menard, Cedric, Dogan, Ahmet, Yang, Lei, Rimsza, Lisa M., Bantilan, Kurt, Martin, Haley, Lei, Matthew, Mohr, Sydney, Kurilovich, Anna, Kudryashova, Olga, Postovalova, Ekaterina, Nardi, Valentina, Abramson, Jeremy S., Chiarle, Roberto, Zelenetz, Andrew D., Louissaint, Abner

Volltext

Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphoc... von Soumerai, Jacob D, Mato, Anthony R, Dogan, Ahmet, Seshan, Venkatraman E, Joffe, Erel, Flaherty, Kelsey, Carter, Jason, Hochberg, Ephraim, Barnes, Jeffrey A, Hamilton, Audrey M, Abramson, Jeremy S, Batlevi, Connie L, Matasar, Matthew J, Noy, Ariela, Owens, Colette N, Palomba, M Lia, Kumar, Anita, Takvorian, Tak, Ni, Ai, Choma, Morgan, Friedman, Chaya, Chadha, Puja, Simkins, Elizabeth, Ruiters, Jade, Sechio, Sidney, Portman, Daneal, Ramos, Lauren, Nolet, Natascha, Mahajan, Neena, Martignetti, Rosalba, Mi, Joanna, Scorsune, Krista, Lynch, Julia, McGree, Brianne, Hughes, Stephanie, Grieve, Clare, Roeker, Lindsey E, Thompson, Meghan, Johnson, P Connor, Roshal, Mikhail, Huang, Jane, Biondo, Juliana, Wu, Qun, Jacob, Allison, Abdel-Wahab, Omar, Zelenetz, Andrew D

Volltext

Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach von Roeker, Lindsey E, Feldman, Tatyana A, Soumerai, Jacob D, Falco, Victoria, Panton, Gail, Dorsey, Colleen, Zelenetz, Andrew D, Falchi, Lorenzo, Park, Jae H, Straus, David J, Pena Velasquez, Camila, Lebowitz, Sonia, Fox, Yehudit, Battiato, Kristen, Laudati, Carissa, Thompson, Meghan C, McCarthy, Elizabeth, Kdiry, Sabrina, Martignetti, Rosalba, Turpuseema, Teja, Purdom, Michelle, Paskalis, Dana, Miskin, Hari P, Sportelli, Peter, Leslie, Lori A, Mato, Anthony R

Volltext

Case 7-2019: A 73-Year-Old Woman with Swelling of the Right Groin and Fever von Soumerai, Jacob D, Tajmir, Shahein H, Hirsch, Martin S, Massoth, Lucas R

Volltext

Metabolic parameters predict survival and toxicity in chimeric antigen receptor T‐cell therapy‐treated relapsed/refractory large B‐cell lymphoma von Ababneh, Hazim S., Ng, Andrea K., Abramson, Jeremy S., Soumerai, Jacob D., Takvorian, Ronald W., Frigault, Matthew J., Patel, Chirayu G.

Volltext

Toxicities and outcome after CD19‐directed chimeric antigen receptor T‐cell therapy for secondary neurolymphomatosis von Kaulen, Leon D., Karschnia, Philipp, Doubrovinskaia, Sofia, Abramson, Jeremy S., Martinez‐Lage, Maria, Shankar, Ganesh, Choi, Bryan D., Barnes, Jeffrey A., El‐Jawahri, Areej, Hochberg, Ephraim P., Johnson, P. Connor, Soumerai, Jacob D., Wick, Wolfgang, Maus, Marcela V., Chen, Yi‐Bin, Frigault, Matthew J., Dietrich, Jorg

Volltext

Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells von Karschnia, Philipp, Arrillaga-Romany, Isabel C, Eichler, April, Forst, Deborah A, Gerstner, Elizabeth, Jordan, Justin T, Ly, Ina, Plotkin, Scott R, Wang, Nancy, Martinez-Lage, Maria, Winter, Sebastian F, Tonn, Joerg-Christian, Rejeski, Kai, von Baumgarten, Louisa, Cahill, Daniel P, Nahed, Brian V, Shankar, Ganesh M, Abramson, Jeremy S, Barnes, Jeffrey A, El-Jawahri, Areej, Hochberg, Ephraim P, Johnson, P Connor, Soumerai, Jacob D, Takvorian, Ronald W, Chen, Yi-Bin, Frigault, Matthew J, Dietrich, Jorg

Volltext

The immunophenotypic spectrum of primary mediastinal large B‐cell lymphoma reveals prognostic biomarkers associated with outcome von Bledsoe, Jacob R., Redd, Robert A., Hasserjian, Robert P., Soumerai, Jacob D., Nishino, Ha T., Boyer, Daniel F., Ferry, Judith A., Zukerberg, Lawrence R., Harris, Nancy Lee, Abramson, Jeremy S., Sohani, Aliyah R.

Volltext